Company Information
Industry 制造业
Company Introduction 西藏诺迪康药业股份有限公司于1999年7月14日在西藏自治区创立,1999年7月21日在上海证券交易所上网交易,是西藏自治区第一家高新技术制药上市企业,股票名称:西藏药业,股票代码:600211。公司自成立以来,被认定为国家级高新技术企业和农业产业化重点龙头企业,公司图形商标(祥云图)经国家工商总局认定为中国驰名商标。公司荣获中国民族医药协会科学技术进步奖一等奖,中国上市公司口碑榜——生物医药最具成长上市公司、金牛最具投资价值奖,四川省科技进步奖一等奖等诸多荣誉。 公司秉承“科学成就健康,健康成就未来”的理念,经过二十余年的发展,已成长为集研发、生产、销售为一体的现代化医药企业。公司已建成一个企业技术中心;三个符合GMP标准的生物制品、藏药制品和中药制品的药品生产基地;一个符合GAP标准的中藏药材种植基地;以及一个疫苗生产基地。公司目前在西藏、四川、上海和香港等地拥有四川诺迪康威光制药有限公司、成都诺迪康生物制药有限公司、西藏诺迪康藏药材开发有限公司、西藏诺迪康医药有限公司、香港拓普瑞吉药业有限公司、西藏氧道大健康生命科学有限公司、上海欣活生物科技有限公司、西藏诺迪康科技发展有限公司、西藏诺迪康生物医药销售有限公司九家下属子公司。 公司产品涵盖生物制药、藏药、中药和化学药;涉及心脑血管、肝胆疾病、骨科止痛、风湿、感冒用药等领域。核心产品有公司自主研发的国内首个用于急性心衰治疗的国家生物制品一类新药“新活素”、以藏药材红景天为原料治疗和预防心脑血管疾病的“诺迪康”、治疗冠心病最有效的国际心血管疾病一线药物“依姆多”;此外,公司还拥有治疗各类关节和肌肉疼痛的中国民族医药协会重点推荐外用药“雪山金罗汉止痛涂膜剂”;处方源自《四部医典》治疗肝胆疾病的现代藏药“十味蒂达胶囊”;治疗儿童急性上呼吸道感染的纯中药制剂“小儿双清颗粒”等国家级中药优秀品种。
Main Business 主要生产、销售胶囊剂、生物制剂、颗粒剂、涂膜剂等
Legal Representative 陈达彬
Top Executives
董事长:陈达彬
副董事长:周裕程
董事:李玉芳,吴三燕,马列一,郭远东
独立董事:满加云,张宇,林建昆
Top 5 Shareholder
Shareholder name Nature Holding Date
西藏康哲企业管理有限公司流通A股32.28%30/06/2024
西藏华西药业集团有限公司流通A股17.42%30/06/2024
北京新凤凰城房地产开发有限公司流通A股3.19%30/06/2024
深圳市康哲药业有限公司流通A股3.11%30/06/2024
西藏科技创新投资有限责任公司流通A股1.99%30/06/2024
Company Secretary 刘岚
Solicitors 北京市中伦律师事务所
Auditors 瑞华会计师事务所(特殊普通合伙)
Tel No 028-86653915
Fax No 028-86660740
Website www.xzyy.cn
Email zqb@xzyy.cn
Company Address
Register: 西藏拉萨经济技术开发区A区广州路3号
Office: 西藏拉萨经济技术开发区A区广州路3号/四川省成都市锦江区三色路427号
Listing Date 21/07/1999
Shares Capital
Shares Capital: 322,319,196
Total A Share: 322,319,196
Listed A Share: 322,319,196
Non-tradable A Share: 0
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 3.230
DPS(RMB)* ¥ 1.939
NBV Per Share(RMB)* ¥ 13.490
Market Capitalization(RMB) 13.183B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.